Myocardial IL-6 regulation by neurohormones--an in vitro superfusion study

Brain Behav Immun. 2003 Aug;17(4):245-50. doi: 10.1016/s0889-1591(03)00053-9.

Abstract

Background: Interleukin-6 (IL-6) is expressed in the myocardium and has been implicated in cell proliferation, negative inotropic effects and myocardial hypertrophy. To determine whether myocardial IL-6 is modified by neurohumoral and immunoregulatory stimuli, we studied the effects of lipopolysaccharide (LPS), corticosterone (CS), isoproterenol and angiotensin II on myocardial IL-6 secretion in superfused myocardium.

Methods: Slices of rat left ventricular myocardium were superfused in 80 microl chambers for up to 5h. LPS (1, 50, and 100 microg/ml), CS (10(-7), 10(-6), and 10(-5)M, DSMO as vehicle), isoproterenol (10(-6), 10(-7), and 10(-8)M) and angiotensin II (10(-5), 10(-7), and 10(-9)M) were added to the culture medium at hour 2. IL-6 was measured in the perfusate by ELISA.

Results: Physiological corticosterone concentrations (10(-7)M) resulted in an increase in IL-6 concentration (142%) while high doses of steroid decreased IL-6 significantly (CS 10(-6)M: 88+/-14%,p<.05; CS 10(-5): 91+/-9%,p<.05) after 5h. Left ventricular IL-6 secretion was significantly stimulated by LPS 50 microg/ml (3262+/-1684% vs. CTRL: 116+/-34%, p<.01). Isoproterenol treatment increased in IL-6 secretion compared to controls with and without CS, while angiotensin II reduced IL-6 concentration only in combination with CS.

Conclusion: Myocardial IL-6 secretion is modulated by physiological concentrations of corticosterone or angiotensin II and can be induced by LPS or isoproterenol, indicating a tight regulation of this cytokine. Suppression of cytokine expression within the heart might be a potential therapeutic goal in the treatment of various cardiovascular diseases.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / physiology
  • Animals
  • Cardiotonic Agents / pharmacology
  • Corticosterone / physiology
  • Dose-Response Relationship, Drug
  • Interleukin-6 / metabolism*
  • Isoproterenol / pharmacology
  • Lipopolysaccharides / pharmacology
  • Male
  • Myocardium / metabolism*
  • Organ Culture Techniques
  • Perfusion
  • Rats
  • Rats, Wistar

Substances

  • Cardiotonic Agents
  • Interleukin-6
  • Lipopolysaccharides
  • Angiotensin II
  • Isoproterenol
  • Corticosterone